Authors: Barry, C Cole, S Fourie, B Geiter, L Gosey, L Grosset, J Kanyok, T Laughon, B Mitchison, D Nunn, P O'Brien, R Robinson, T Annick-Mouries, M Cynamon, M Duncan, K Goldberger, M Gutteridege, W Kioy, D Pablos-Mendez, A Orme, I Rieder, H Roscigno, G Vernon, A

Citation: C. Barry et al., Scientific blueprint for tuberculosis drug development - Global alliance for TB drug development, TUBERCULOSI, 81, 2001, pp. 1-52

Authors: Onyebujoh, PC Levin, JB Fourie, FB Garhiram, V Tembe, LC Phili, NP Mthiyane, TCP Moniwa, T Bayer, G Ramajoe, IM Mncwabe, TAB Mallisar, LGM Saul, TNM Levin, JB Jackson, THFG Suparsad, S Fine, PEM Pendlebury, DJS Fine, E Houghton, I Clyde, J Vos, HP Padayatchi, N Pala, A Ramjee, A Ramjee, M Ramdeen, J Masters, IH Osbourne, G Naidu, K Bamba, S Mazur, B Czarnocki, R Landers, K Ndlovu, G Maphumulo, N Garhiram, V Sturm, AW Moodley, J Pillay, C Roux, L Moodley, R Sarawan, A Jali, T Manickam, F Smith, A",Gopaul,"Durosanmi, T Moonsammy, R Wyld, P McCallum, J Fulton, C Bisset, K Henderson, S Stewart, D Nticinka, O Watson, D Tuckwell, N Kennard, D Stanford, JL Rook, GA Grange, JM Zumla, AA Bateman, E Hopwell, P Darbyshire, J Geiter, L Nunn, A Weyer, K

Citation: Pc. Onyebujoh et al., Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial, LANCET, 354(9173), 1999, pp. 116-119